This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Axon 2 Powers AppLovin's Explosive Growth in Mobile Advertising
by Zacks Equity Research
APP's AI engine Axon 2 has driven massive ad growth, but a lofty valuation and slowing momentum now test investor confidence.
Veeva's Vault Vision: Can It Thrive After Parting With Salesforce?
by Harshit Gupta
VEEV stock climbs 36% YTD as it accelerates its shift off Salesforce, betting on Vault to power future growth in life sciences.
Salesforce.com (CRM) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
In the most recent trading session, Salesforce.com (CRM) closed at $267.22, indicating a +1.38% shift from the previous trading day.
Veeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy?
by Harshit Gupta
VEEV's split from Salesforce sets the stage for a high-stakes CRM showdown as both firms double down on life sciences innovation.
Salesforce vs. HubSpot: Which CRM Stock Is the Smarter Buy Now?
by Anirudha Bhagat
HUBS outpaces CRM in sales growth and market momentum, making it a better investment pick despite the premium.
Why Salesforce.com (CRM) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know
by Zacks Equity Research
Salesforce.com (CRM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Pegasystems Set to Report Q2 Earnings: Is the Stock a Buy?
by Subhasish Mukherjee
PEGA's Q2 2025 results are expected to reflect cloud and GenAI momentum, aided by strong cash flow, despite forex and competitive pressures.
Is It Worth Investing in Salesforce.com (CRM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Salesforce.com (CRM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Salesforce Bets Big on Agentforce: Can AI Agents Power Growth?
by Anirudha Bhagat
Agentforce platform hits $100 million ARR in two quarters as CRM ramps up AI agent adoption and integration.
Veeva Systems' Vault CRM Momentum Builds With Top Biopharma Adoptions
by Harshit Gupta
VEEV sees rising Vault CRM adoption among top biopharma firms, driven by new features, fueling customer migration and growth.
Has DOCU's 15% Year-to-Date Decline Created a Buying Opportunity?
by Shuvra Shankar Dey
DOCU is down 15% YTD despite solid cash flow and key integrations, but is this a reset or just a stall?
Salesforce.com (CRM) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
Salesforce.com (CRM) closed at $263.97 in the latest trading session, marking a -2.57% move from the prior day.
Salesforce's Data Cloud ARR Soars 120%: Is It the Next Sales Lever?
by Anirudha Bhagat
CRM's Data Cloud tops $1B in ARR with 120% YoY growth, powering AI tools and driving major deals across its platform.
Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Here is What to Know Beyond Why Salesforce Inc. (CRM) is a Trending Stock
by Zacks Equity Research
Salesforce.com (CRM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Salesforce Slides 17% in Six Months: Should You Still Hold the Stock?
by Anirudha Bhagat
CRM is down 17% in six months, but its dominance in the customer relationship management software space, AI focus and lower valuation may justify holding on.
Pega Cloud Drives Subscription Revenues: Will It Aid PEGA's Growth?
by Zacks Equity Research
Pegasystems' cloud growth accelerates with a 23% increase in ACV, driving subscriptions higher as AI and automation gain traction.
UiPath Stock Jumps 36% in Three Months: Time to Buy PATH?
by Shuvra Shankar Dey
PATH jumps 36% in three months as strong partnerships, solid growth and discounted valuation draw investor interest.
AppLovin Stock Surges 47% in 3 Months: Still Time to Ride the Wave?
by Shuvra Shankar Dey
APP surges 47% in 3 months as Axon 2 drives $10B ad spend and record profits. Does the rally still have room to run?
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Salesforce.com (CRM) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
Salesforce.com (CRM) reached $272.15 at the closing of the latest trading day, reflecting a +1.09% change compared to its last close.
PLTR Stock Rises 75% Year to Date: Still a Buy, or Time to Wait?
by Shuvra Shankar Dey
PLTR is up 75% YTD, fueled by booming AI demand. But with a sky-high valuation, is it time to pause before buying in?
Adobe's Record Q2 Cash Flow Sets the Path: A Key to Future Momentum?
by Zacks Equity Research
ADBE posts record fiscal Q2 cash flow of $2.19B, fueled by AI features and subscriptions, reinforcing its growth trajectory.
Palantir's AI Platform Moves From Hype to Hyper-Execution
by Shuvra Shankar Dey
PLTR's AI Platform fuels 71% U.S. commercial growth as bootcamps speed adoption and large enterprise deals surge.